Antiparasitic Ivermectin can End Pandemic

Use of common antiparasitic ivermectin can end COVID-19 pandemic, claimed a peer-reviewed research. The drug significantly reduces the risk of contracting the deadly respiratory disease when used regularly.

Peer reviewed by medical experts that included three US government senior scientists and published in the American Journal of Therapeutics, the research is the most comprehensive review of the available data taken from clinical, in vitro, animal, and real-world studies.

Test your Knowledge on Coronavirus (COVID-19)
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to spike up with the “second wave” of COVID-19.

With spiking effects of the second wave of coronavirus, the best way to keep it at bay is to follow COVID-appropriate safety practices like wearing a mask, regularly cleaning your hands, and coughing into a bent elbow or tissue along with physical distancing (6 feet about 2 arm's length), that may help evade the severity of COVID-19 infection.

‘The ivermectin distribution campaigns repeatedly led to rapid population-wide decreases in morbidity and mortality.’

Tweet it Now

Led by the Front Line COVID-19 Critical Care Alliance (FLCCC), a group of medical and scientific experts reviewed published peer-reviewed studies, manuscripts, expert meta-analyses, and epidemiological analyses of regions with ivermectin distribution efforts all showing that ivermectin is an effective prophylaxis and treatment for COVID-19.

"We did the work that the medical authorities failed to do, we conducted the most comprehensive review of the available data on ivermectin," said Pierre Kory, MD, president and chief medical officer of the FLCCC.

Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.

"We applied the gold standard to qualify the data reviewed before concluding that ivermectin can end this pandemic."

A focus of the manuscript was on the 27 controlled trials available in January 2021, 15 of which were randomised controlled trials (RCT's).

Double Mutant COVID Variant Shows Enhanced Host Cell Entry
B.1.617, the double mutant variant of coronavirus that has emerged in India, entered certain types of lung and intestine cells with slightly increased efficiency.

Consistent with numerous meta-analyses of ivermectin RCT's since published by expert panels from the UK, Italy, Spain and Japan, they found large, statistically significant reduction in mortality, time to recovery and viral clearance in Covid-19 patients treated with ivermectin.

"Our latest research shows, once again, that when the totality of the evidence is examined, there is no doubt that ivermectin is highly effective as a safe prophylaxis and treatment for Covid-19," said Paul E. Marik, founding member of the FLCCC and Chief, Pulmonary and Critical Care Medicine at Eastern Virginia Medical School.

COVID by Numbers: Global Caseload Tops 156.4 Million
Globally, COVID-19 caseload has topped 156.4 million, while the deaths have surged to more than 3.26 million, according to the Johns Hopkins University.

Many regions around the world now recognise that ivermectin is a powerful prophylaxis and treatment for Covid-19.

South Africa, Zimbabwe, Slovakia, Czech Republic, Mexico, and India have approved the drug for use by medical professionals.

"We are calling on regional public health authorities and medical professionals around the world to demand that ivermectin be included in their standard of care right away so we can end this pandemic once and for all," Marik noted.

Source-IANS